{"id":19087,"date":"2026-08-17T05:19:51","date_gmt":"2026-08-17T08:19:51","guid":{"rendered":"https:\/\/rtmedical.com.br\/tmp-en-1786954790466\/"},"modified":"2026-08-17T05:19:58","modified_gmt":"2026-08-17T08:19:58","slug":"medicare-ntap-radiology-ai","status":"publish","type":"post","link":"https:\/\/rtmedical.com.br\/en\/medicare-ntap-radiology-ai\/","title":{"rendered":"Medicare Adds Payment for Inpatient Radiology AI"},"content":{"rendered":"

Medicare has approved a new technology add-on payment (NTAP) for a radiology artificial intelligence tool under its finalized inpatient payment rule. In practice: starting October 1, US hospitals using Aidoc’s BriefCase-Triage can collect up to $137.53 per case<\/strong> in 2027 \u2014 the clearest sign yet that AI triage on CT has stopped being pure cost and acquired a revenue line of its own.<\/p>\n

What exactly got approved<\/h2>\n

The covered technology is CARE (Clinical AI Reasoning Engine) Multi-Triage CT Body, which analyzes computed tomography studies and flags potentially urgent findings \u2014 appendicitis and bowel obstruction among them \u2014 so they climb the reading queue. Eligible use will be identified by ICD-10-PCS procedure code XEZ5XKC<\/strong>, described as computer-aided triage and notification for imaging abnormalities in computed tomography of chest, abdomen and pelvis, new technology group 12.<\/p>\n

\"Radiologist
AI triage reorders the reading queue for chest, abdomen and pelvis CT. Photo: Tima Miroshnichenko\/Pexels<\/figcaption><\/figure>\n

The figure is not arbitrary. According to the American College of Radiology’s summary of the final rule, $137.53 represents roughly 65% of the average cost of the technology<\/strong> \u2014 precisely the ceiling NTAP legislation allows. The benefit runs up to three years from October, the program’s standard window.<\/p>\n

The surrounding package gives a sense of scale: Medicare approved 22 new products through the “alternative” pathway \u2014 reserved for devices that also earned FDA breakthrough device designation \u2014 plus 8 more through the traditional pathway. All told, CMS expects to spend an additional $779 million on inpatient cases involving emerging innovations in fiscal 2027, mostly driven by NTAP.<\/p>\n

Why reimbursement, not regulation, is the real bottleneck<\/h2>\n

The mechanics deserve a word, because they run counter to intuition. Medicare inpatient payment is prospective and bundled by DRG: the hospital gets a fixed amount for the episode regardless of what it consumed. An expensive new technology therefore lands as expense with no offset \u2014 the AI software comes out of the hospital’s pocket and shows up on no billing line. NTAP exists precisely to break that logic for a limited period, covering up to 65% of the incremental cost of technologies that are simultaneously new, inadequately paid under the current DRG, and clinically superior.<\/p>\n

That is why this news carries more weight than the dollar figure suggests. Ever since Viz.ai secured the first NTAP for an imaging algorithm \u2014 large vessel occlusion detection in stroke \u2014 the list of radiology AI products with payment of their own stayed remarkably short, even as regulatory clearances exploded. We mapped that imbalance when listing the top AI vendors by number of FDA approvals<\/a>: market authorization was never the problem. Getting paid is.<\/p>\n

“Health systems are under increasing pressure to help patients receive accurate diagnoses sooner while managing growing imaging demand and persistent workforce shortages,” Elad Walach, CEO and co-founder of New York-based Aidoc, said in an August 13 statement. “By creating a reimbursement pathway for eligible use of diagnostic AI, the NTAP program is helping patients get earlier access to this transformative new technology.”<\/p>\n

The regulatory path behind the product<\/h2>\n

CT Body Triage received FDA breakthrough device designation in September 2025 and 510(k) clearance in January of this year. That sequence is not bureaucratic trivia: breakthrough designation is the prerequisite for the alternative NTAP pathway, which waives the demonstrated “substantial clinical improvement” criterion \u2014 a genuine relief for AI devices, whose hard-outcome literature remains thin.<\/p>\n

Aidoc had already been stacking regulatory milestones. What is different now is the nature of the milestone: this is not a safety clearance, it is money.<\/p>\n

What it means for running a service<\/h2>\n

For the radiologist, the change is operational before it is financial. AI triage does not issue a report; it reorders the worklist. A study with suspected bowel obstruction moves up and gets read in minutes rather than hours. The gain shows up in time-to-treatment, not in final accuracy \u2014 which means you have to measure the right thing. A department that does not track turnaround time by priority tier will never see the algorithm’s value on a spreadsheet.<\/p>\n

One side effect deserves attention: reordering the queue changes the on-call radiologist’s cognitive load and can breed alert fatigue if the false-positive rate runs high. Decide up front who audits dismissed alerts, and how often. It is equally prudent to reconcile flagged volume against confirmed cases in the first quarter of use \u2014 data most departments simply never collect.<\/p>\n

Outside the US the funding picture looks very different. Most health systems have no specific code for AI triage at all, which pushes the business case toward indirect gains: shorter length of stay, fewer repeat exams, better use of on-call coverage. That makes it an operational efficiency story rather than a billing one \u2014 and in an environment where US radiology is already arguing over 2027 Medicare fee schedule cuts<\/a> and the ACR is mapping the impact code by code<\/a>, the distinction between new revenue and internal savings decides who gets the purchase approved.<\/p>\n

What to watch over the next few months<\/h2>\n

Three indicators are worth tracking. First, how many hospitals actually code XEZ5XKC \u2014 an approved NTAP is not a billed NTAP, and undercoding is the norm with new technology. Second, whether CMS extends the same reasoning to the outpatient setting, where most imaging volume lives. Third, whether other vendors replicate the breakthrough-plus-alternative-pathway route, which would turn a one-off into a precedent.<\/p>\n

The structural limitation stands: NTAP is temporary by design. After three years the cost folds back into the DRG and the hospital has to prove the algorithm pays for itself. Whoever starts measuring outcomes now arrives in 2030 with data. Whoever merely switches the software on will arrive with an invoice.<\/p>\n

Source:<\/strong> Health Imaging \/ Radiology Business \u2014 Medicare approves new technology add-on payment for inpatient radiology AI solution<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Medicare approved an NTAP of up to $137.53 per case for Aidoc’s CT triage AI. Inside the rule and what it changes for payment.<\/p>\n","protected":false},"author":1,"featured_media":19069,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"ngg_post_thumbnail":0,"_rt_cluster":"","fifu_image_url":"","fifu_image_alt":"","footnotes":""},"categories":[234,102,100],"tags":[],"class_list":["post-19087","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medical-billing","category-ai","category-radiology"],"aioseo_notices":[],"rt_seo":{"title":"","description":"Medicare approved an NTAP of up to $137.53 per case for Aidoc's CT triage AI. How the reimbursement mechanics work.","canonical":"","og_image":"","robots":"index,follow","schema_type":"Article","include_in_llms":true,"llms_label":"Medicare NTAP for CT triage AI","llms_summary":"Medicare approved a new technology add-on payment of up to $137.53 per case in 2027 for Aidoc's CARE Multi-Triage CT Body, billed under ICD-10-PCS code XEZ5XKC, running three years from October.","faq_items":[],"video":[],"gtin":"","mpn":"","brand":"","aggregate_rating":[]},"_links":{"self":[{"href":"https:\/\/rtmedical.com.br\/en\/wp-json\/wp\/v2\/posts\/19087\/"}],"collection":[{"href":"https:\/\/rtmedical.com.br\/en\/wp-json\/wp\/v2\/posts\/"}],"about":[{"href":"https:\/\/rtmedical.com.br\/en\/wp-json\/wp\/v2\/types\/post\/"}],"author":[{"embeddable":true,"href":"https:\/\/rtmedical.com.br\/en\/wp-json\/wp\/v2\/users\/1\/"}],"replies":[{"embeddable":true,"href":"https:\/\/rtmedical.com.br\/en\/wp-json\/wp\/v2\/comments\/?post=19087"}],"version-history":[{"count":1,"href":"https:\/\/rtmedical.com.br\/en\/wp-json\/wp\/v2\/posts\/19087\/revisions\/"}],"predecessor-version":[{"id":19089,"href":"https:\/\/rtmedical.com.br\/en\/wp-json\/wp\/v2\/posts\/19087\/revisions\/19089\/"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rtmedical.com.br\/en\/wp-json\/wp\/v2\/media\/19069\/"}],"wp:attachment":[{"href":"https:\/\/rtmedical.com.br\/en\/wp-json\/wp\/v2\/media\/?parent=19087"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rtmedical.com.br\/en\/wp-json\/wp\/v2\/categories\/?post=19087"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rtmedical.com.br\/en\/wp-json\/wp\/v2\/tags\/?post=19087"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}